# kaal:claim:2317580-020

**Claim.** By prescribing the number of board meetings devoted to compliance review and requiring specific board resolutions, CIA provisions let the government contractually determine how and when a board will interact.

**Type.** mechanism  **Support.** evidenced

**Holds when.**

- CIAs containing board specific provisions, as in the Allergan, Pfizer, and AstraZeneca agreements

**Source quote.**

> In effect, these provisions allow the government to contractually determine how and when a board will interact.

**From.** Wulf A. Kaal, Elizabeth R. Malay, *The Role of Corporate Integrity Agreements in the Expansion of Fiduciary Duties* (2013), III.3 Reach and Scope, page 13

**Cite as.** Wulf A. Kaal, Elizabeth R. Malay, The Role of Corporate Integrity Agreements in the Expansion of Fiduciary Duties (2013). SSRN: https://ssrn.com/abstract=2317580

**Verify.** sha256 of source PDF `50973e1e820aef47a4e7ffdbdcb513d03f1845643fcf4fa5910e9528a0b7dac2` at https://raw.githubusercontent.com/wulfkaal/Academic-Papers/main/papers/pdf/Kaal%20and%20Malay%20-%202013%20-%20The%20Role%20of%20Corporate%20Integrity%20Agreements%20in%20the%20Expansion%20of%20Fiduciary%20Duties.pdf

**Topics.** corporate-governance, systemic-risk, compliance

**Keywords.** board-meetings, board-resolutions, government-control, corporate-integrity-agreements

**Canonical form.** This markdown file is the canonical hashed representation of the claim. Its sha256 is the content hash used for attestation.
